α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial. [electronic resource]
Producer: 20130722Description: 623 p. digitalISSN:- 1471-2407
- Adult
- Aged
- Antigens, Neoplasm -- immunology
- Brain Neoplasms -- therapy
- Cancer Vaccines -- immunology
- Dendritic Cells -- immunology
- Female
- Glioma -- therapy
- HLA-A2 Antigen -- genetics
- HLA-A24 Antigen -- genetics
- Humans
- Immunotherapy, Active -- methods
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- therapy
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.